InsidersTradesSigma
Discover the full record of transactions filed by Henrik Stenqvist, Chief Financial Officer. Director active across 2 companies, notably Swedish Orphan Biovitrum AB (publ). Aggregated, 1 disclosures have been logged. The latest transaction was disclosed on 24 October 2025 — Purchase. Regulator: FIN-FSA. All data is accessible without signup.
1 of 1 declaration
Henrik Stenqvist is the Chief Financial Officer of Swedish Orphan Biovitrum AB (publ), a biopharmaceutical company. He is responsible for financial management and the economic strategy of the company.